drugset / Trial / NCT01204112

Estimate The Effect Of Repeat-Dose Rifampin On The Pharmacokinetics Of CP-690,550 In Healthy Volunteers

NCT01204112

Phase 1 Completed 12 enrolled Pfizer
Non-randomizedSingle-groupOpen-labelBasic science

Summary

The current study is designed to estimate the effect of rifampin (600 mg orally every 24 hours for 7 days) on pharmacokinetics of single 30 mg dose (CP-690,550) in normal healthy volunteers

Timeline

Start
2010-09
Primary completion
2010-10
Completion
2010-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Rifampin Small molecule 600 mg Oral
Subject Tofacitinib Small molecule 30 mg Oral

Indications

No indication recorded.